EUVIMEDEUVIMED entdecken
Open Access

Identification and validation of dyslipidemia and glutamate metabolism-associated gene diagnostic and therapeutic repurposing signature for Acute myocardial infarction patients: insights from integrative bioinformatic and multi-omic studies

Hanwei Zhao, Wenge Chen, Ran Cheng, Shuting Ren, Chuang Guo

Cytotechnology · 2026-08 · 78 (4)

DOI: 10.1007/s10616-026-00979-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytotechnology, online erschienen am 26.05.2026. Verfasst von Hanwei Zhao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Peripheral Vascular Disease Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, 150040 Harbin, China. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Dyslipidemia and glutamate metabolism (DG) plays a crucial role in the pathogenesis of Acute myocardial infarction (AMI). Hence, deeper understanding of DG in AMI paves the way for the clinical applications of AMI.

Methods

In combination of PPI network and Limma framework, we first identified DG-associated shared differentially expressed genes (DEGs) from AMI patient bulk profile (GSE61144) and DG-associated gene list acquired from GEO and Genecard databases respectively. In another AMI patient bulk profile (GSE28454), we performed consensus clustering for classifying patient into 2 subgroups based on shared DG-related DEGs. By employing 2 machine learning algorithms (RF and SVM) in AMI patient training set (GSE109048), we identified DG-related hub gene, and then evaluated its diagnostic performance across GSE61144, GSE109048 and GSE66360(independent AMI patient bulk profile). Indeed, the molecular feature of DG-related hub gene was deciphered at GSE109048 and AMI single-cell transcriptomic profile (GSE269269). Finally, in vitro study illustrated the expression pattern of DG-related hub gene and DGIDB database with molecular docking proved the potential therapeutic framework for combating AMI.

Results

We discovered that DG-associated molecular subgroups and down-regulated expression gene signature CALR was diagnostic biomarkers for AMI, and Trentinoin should be considered as novel drug repurposing framework for the treatment of AMI.

Conclusion

We first pointed out that DG should be considered as diagnostic and therapeutic repurposing targets for the clinical translation of AMI, which can guide AMI patient personalized and precision medicine.

Schlagwörter

Stichwörter der Autor:innen

Acute myocardial infarctionDiagnostic biomarkersDrug reproposingDyslipidemiaGlutamate metabolism

Autor:innen und Institutionen

  • Peripheral Vascular Disease Department, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine, 150040 Harbin, China.
  • Department of Blood Purification, Heilongjiang University of Chinese Medicine, 150040 Harbin, China.

Zitieren

APA

Zhao, H., Chen, W., Cheng, R., Ren, S., & Guo, C. (2026). Identification and validation of dyslipidemia and glutamate metabolism-associated gene diagnostic and therapeutic repurposing signature for Acute myocardial infarction patients: insights from integrative bioinformatic and multi-omic studies. Cytotechnology, 78(4). https://doi.org/10.1007/s10616-026-00979-9

Vancouver

Zhao H, Chen W, Cheng R, Ren S, Guo C. Identification and validation of dyslipidemia and glutamate metabolism-associated gene diagnostic and therapeutic repurposing signature for Acute myocardial infarction patients: insights from integrative bioinformatic and multi-omic studies. Cytotechnology. 2026;78(4). doi:10.1007/s10616-026-00979-9

BibTeX
@article{Zhao2026,
  author = {Zhao, Hanwei and Chen, Wenge and Cheng, Ran and Ren, Shuting and Guo, Chuang},
  title = {Identification and validation of dyslipidemia and glutamate metabolism-associated gene diagnostic and therapeutic repurposing signature for Acute myocardial infarction patients: insights from integrative bioinformatic and multi-omic studies},
  journal = {Cytotechnology},
  year = {2026},
  volume = {78},
  number = {4},
  doi = {10.1007/s10616-026-00979-9}
}
Kostenlos starten →